Literature DB >> 18474055

Preliminary development and validation of the Jaw Functional Limitation Scale.

Richard Ohrbach1, Carl Granger, Thomas List, Samuel Dworkin.   

Abstract

OBJECTIVE: Functional limitation is a construct distinct from disability, but the distinction between these constructs is often blurred when measuring jaw status because of content overlap in measurement instruments that include items pertaining to mechanical jaw functions, jaw functions that have obvious social implications, and only social functions. We describe analyses in support of assessing functional limitation as distinct from disability by using both factor analysis and the Rasch measurement model in reanalyzing two existing instruments and then create a preliminary version of a new instrument that has excellent psychometric properties. STUDY DESIGN AND
SETTING: Subjects in three separate studies from two university settings completed two existing self-report instruments (Research Diagnostic Criteria for Temporomandibular Disorders and Mandibular Functional Impairment Questionnaire). Rasch methodology, factor analysis, and the combination of both were used in these analyses. Unidimensionality, in support of an instrument assessing a single construct, was also assessed.
RESULTS: Problems identified in the existing instruments included scaling, internal reliability, length, unidimensionality, and content validity; the preliminary version of the Jaw Functional Limitation Scale (JFLS) resolves these problems critical to delineating functional limitation and it exhibits internal reliability coefficients of 0.82 for persons and 0.99 for items. Construct validity, via convergent and discriminant validity with other associated constructs, of the JFLS was established via low correlations with depression, anxiety, somatization, pain interference, pain-free opening, and palpation sensitivity, and via moderate correlations with pain and jaw symptoms.
CONCLUSION: While areas of further development are outlined, we conclude that this preliminary version of the JFLS is a valid instrument for the measurement of temporomandibular disorder (TMD)-related functional limitation, and consequently delineates functional limitation from disability.

Entities:  

Mesh:

Year:  2008        PMID: 18474055     DOI: 10.1111/j.1600-0528.2007.00397.x

Source DB:  PubMed          Journal:  Community Dent Oral Epidemiol        ISSN: 0301-5661            Impact factor:   3.383


  16 in total

1.  Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Richard Ohrbach; Roger B Fillingim; Flora Mulkey; Yoly Gonzalez; Sharon Gordon; Henry Gremillion; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Joel D Greenspan; Charles Knott; William Maixner; Gary Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†.

Authors:  Eric Schiffman; Richard Ohrbach; Edmond Truelove; John Look; Gary Anderson; Jean-Paul Goulet; Thomas List; Peter Svensson; Yoly Gonzalez; Frank Lobbezoo; Ambra Michelotti; Sharon L Brooks; Werner Ceusters; Mark Drangsholt; Dominik Ettlin; Charly Gaul; Louis J Goldberg; Jennifer A Haythornthwaite; Lars Hollender; Rigmor Jensen; Mike T John; Antoon De Laat; Reny de Leeuw; William Maixner; Marylee van der Meulen; Greg M Murray; Donald R Nixdorf; Sandro Palla; Arne Petersson; Paul Pionchon; Barry Smith; Corine M Visscher; Joanna Zakrzewska; Samuel F Dworkin
Journal:  J Oral Facial Pain Headache       Date:  2014

3.  The Research Diagnostic Criteria for Temporomandibular Disorders. VI: future directions.

Authors:  Gary C Anderson; Yoly M Gonzalez; Richard Ohrbach; Edmond L Truelove; Earl Sommers; John O Look; Eric L Schiffman
Journal:  J Orofac Pain       Date:  2010

4.  The Research Diagnostic Criteria for Temporomandibular Disorders. I: overview and methodology for assessment of validity.

Authors:  Eric L Schiffman; Edmond L Truelove; Richard Ohrbach; Gary C Anderson; Mike T John; Thomas List; John O Look
Journal:  J Orofac Pain       Date:  2010

5.  The Research Diagnostic Criteria for Temporomandibular Disorders. IV: evaluation of psychometric properties of the Axis II measures.

Authors:  Richard Ohrbach; Judith A Turner; Jeffrey J Sherman; Lloyd A Mancl; Edmond L Truelove; Eric L Schiffman; Samuel F Dworkin
Journal:  J Orofac Pain       Date:  2010

6.  Assessment and further development of RDC/TMD Axis II biobehavioural instruments: a research programme progress report.

Authors:  R Ohrbach
Journal:  J Oral Rehabil       Date:  2010-08-04       Impact factor: 3.837

7.  Use of orthopedic manual physical therapy to manage chronic orofacial pain and tension-type headache in an adolescent.

Authors:  Sarah H Stuhr; Darren H Earnshaw; Alison M Duncombe
Journal:  J Man Manip Ther       Date:  2014-02

8.  Clinical orofacial characteristics associated with risk of first-onset TMD: the OPPERA prospective cohort study.

Authors:  Richard Ohrbach; Eric Bair; Roger B Fillingim; Yoly Gonzalez; Sharon M Gordon; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Luda Diatchenko; Ronald Dubner; Joel D Greenspan; Charles Knott; William Maixner; Shad B Smith; Gary D Slade
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

9.  Clinical, psychological, and sensory characteristics associated with headache attributed to temporomandibular disorder in people with chronic myogenous temporomandibular disorder and primary headaches.

Authors:  Inna E Tchivileva; Richard Ohrbach; Roger B Fillingim; Feng-Chang Lin; Pei Feng Lim; Samuel J Arbes; Gary D Slade
Journal:  J Headache Pain       Date:  2021-05-22       Impact factor: 7.277

10.  Smiling, Yawning, Jaw Functional Limitations and Oral Behaviors With Respect to General Health Status in Patients With Temporomandibular Disorder-Myofascial Pain With Referral.

Authors:  Joanna Kuć; Krzysztof Dariusz Szarejko; Maria Gołȩbiewska
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.